KAVERI SEED COMPANY
|
KAVERI SEED COMPANY Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 58.08 | 48.59 | 36.43 | 51.47 | 42.94 |
| CEPS(Rs) | 63.74 | 52.43 | 40.08 | 55.27 | 47.34 |
| DPS(Rs) | 5.00 | 4.00 | 4.00 | 4.00 | 3.00 |
| Book NAV/Share(Rs) | 239.64 | 244.10 | 219.60 | 206.27 | 158.91 |
| Tax Rate(%) | 6.51 | 4.63 | 4.47 | 3.06 | 4.68 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.89 | 22.83 | 20.88 | 28.75 | 27.22 |
| EBIT Margin(%) | 27.95 | 26.73 | 22.98 | 31.03 | 29.36 |
| Pre Tax Margin(%) | 27.93 | 26.71 | 22.96 | 30.98 | 29.31 |
| PAT Margin (%) | 26.11 | 25.47 | 21.94 | 30.03 | 27.94 |
| Cash Profit Margin (%) | 28.55 | 27.39 | 24.10 | 32.18 | 30.69 |
| Performance Ratios | |||||
| ROA(%) | 14.30 | 13.59 | 10.88 | 17.28 | 16.31 |
| ROE(%) | 23.09 | 20.61 | 16.85 | 28.25 | 26.45 |
| ROCE(%) | 24.71 | 21.61 | 17.63 | 29.08 | 27.60 |
| Asset Turnover(x) | 0.55 | 0.53 | 0.50 | 0.58 | 0.58 |
| Sales/Fixed Asset(x) | 2.12 | 2.18 | 2.09 | 2.30 | 2.17 |
| Working Capital/Sales(x) | 1.54 | 1.14 | 1.05 | 1.13 | 1.42 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.47 | 0.46 | 0.48 | 0.43 | 0.46 |
| Receivable days | 38.96 | 41.61 | 40.71 | 39.39 | 39.75 |
| Inventory Days | 232.09 | 252.09 | 278.48 | 239.25 | 235.45 |
| Payable days | 193.88 | 186.30 | 248.25 | 255.93 | 218.52 |
| Valuation Parameters | |||||
| PER(x) | 10.73 | 9.81 | 15.00 | 9.98 | 7.94 |
| PCE(x) | 9.78 | 9.09 | 13.63 | 9.29 | 7.20 |
| Price/Book(x) | 2.60 | 1.95 | 2.49 | 2.49 | 2.14 |
| Yield(%) | 0.80 | 0.84 | 0.73 | 0.78 | 0.88 |
| EV/Net Sales(x) | 2.77 | 2.47 | 3.26 | 2.98 | 2.21 |
| EV/Core EBITDA(x) | 9.12 | 8.63 | 12.99 | 8.98 | 6.88 |
| EV/EBIT(x) | 9.91 | 9.25 | 14.21 | 9.60 | 7.52 |
| EV/CE(x) | 2.58 | 1.94 | 1.65 | 1.55 | 1.28 |
| M Cap / Sales | 2.79 | 2.49 | 3.28 | 2.99 | 2.21 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 7.29 | 10.35 | -6.40 | 11.39 | 14.94 |
| Core EBITDA Growth(%) | 13.83 | 25.77 | -29.08 | 15.05 | 17.34 |
| EBIT Growth(%) | 12.21 | 28.36 | -30.68 | 17.72 | 17.89 |
| PAT Growth(%) | 9.99 | 28.12 | -31.62 | 19.74 | 19.55 |
| EPS Growth(%) | 19.52 | 33.39 | -29.22 | 19.86 | 24.65 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | 0.01 |
| Current Ratio(x) | 1.95 | 2.43 | 2.67 | 2.35 | 2.13 |
| Quick Ratio(x) | 1.00 | 1.34 | 1.29 | 1.29 | 1.03 |
| Interest Cover(x) | 1,316.18 | 1,518.49 | 1,749.45 | 636.67 | 570.81 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of KAVERI SEED COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KAVERI SEED COMPANY | ₹6,270.8 Cr | -3.8% | 18.4% | 102.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,327.7 Cr | -0.3% | 2.7% | 14.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,351.5 Cr | -1.3% | 0.9% | 3.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,298.2 Cr | 0.2% | -13% | -41.3% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹486.4 Cr | 6.1% | -0.8% | NA | Stock Analytics | |
| INDO US BIOTECH | ₹307.6 Cr | -10.4% | -24.8% | -40.9% | Stock Analytics | |
KAVERI SEED COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KAVERI SEED COMPANY | -3.8% |
18.4% |
102.9% |
| SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses
